Finance

Lists
BCTX:NASDAQ
Briacell Therapeutics Corp
3,44 USD
+0,88%
(+0,030) 1D
13-авг., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCTX...
Open
3,42 USD
High
3,54 USD
Low
3,37 USD
Mkt. cap
41,76 млн
Avg. vol.
145,04 миң
Volume
81,93 миң
52-wk high
14,68 USD
52-wk low
2,60 USD
Beta
1,14
Shares outstanding
8,70 млн
No. of employees
22
Open
3,42 USD
High
3,54 USD
Low
3,37 USD
Mkt. cap
41,76 млн
Avg. vol.
145,04 миң
Volume
81,93 миң
52-wk high
14,68 USD
52-wk low
2,60 USD
Beta
1,14
Shares outstanding
8,70 млн
No. of employees
22
News stories
From web sources and news partners
About Briacell Therapeutics Corp
CEO-
Employees22
Founded2006
HeadquartersЗапад Ванкувер, Бритиш Колумбия, Канада
Sector-
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июл.
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,00 млн
6,56 млн
5,92 млн
5,84 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,56 млн
1,76 млн
1,61 млн
1,78 млн
Operating expense
8,55 млн
8,32 млн
7,53 млн
7,62 млн
Total operating expenses
8,55 млн
8,32 млн
7,53 млн
7,62 млн
Operating income
-8,55 млн
-8,32 млн
-7,53 млн
-7,62 млн
Other non operating income
392,34 миң
-69,20 миң
211,78 миң
261,07 миң
EBT including unusual items
-8,16 млн
-8,28 млн
-7,30 млн
-7,24 млн
EBT excluding unusual items
-8,22 млн
-8,37 млн
-7,30 млн
-7,24 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,09 млн
-8,20 млн
-7,22 млн
-7,16 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
33,44 миң
48,48 миң
105,64 миң
219,22 миң
Interest expense
-
-
-
-29,63 миң
Net interest expenses
33,44 миң
48,48 миң
105,64 миң
189,59 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,53 млн
-8,30 млн
-7,50 млн
-7,59 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google колдонмолору